BLUE BIRD CORPORATION financials

  1. Home
  2. Financials
  3. BLBD
BLBD CIK 0001589526

Source: EDGAR filings · Built 2026-06-02T02:29:17Z

Custom taxonomy namespace: ffd

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2024FY 2021
Free Cash Flow 152.36M 95.26M 110.84M -32.02M -32.02M -67.75M
EBITDA 182.75M 154.15M 67.64M -26.65M -26.65M 19.97M
Working Capital 174.83M 87.41M 6.44M 9.70M — 31.29M
Net Debt -132.71M -26.87M 58.13M 148.58M — 165.27M
Gross Margin 20.51% 19.01% 12.26% 4.56% 4.56% 10.55%
Operating Margin 11.29% 10.34% 4.56% -5.08% -5.08% 0.95%
Net Margin 8.63% 7.83% 2.10% -5.72% -5.72% -0.04%
Return on Equity (ROE) 50.00% 66.15% 59.53% -3311.07% -3311.07% 0.89%
Return on Assets (ROA) 20.43% 20.11% 5.70% -12.50% — -0.08%
Current Ratio 1.74× 1.37× 1.03× 1.06× — 1.25×
Debt-to-Equity 0.38× 0.63× 3.43× 115.09× — -5.42×
Effective Tax Rate 25.91% 26.18% 34.69% 21.58% 21.58% 60.21%
Cash Conversion Ratio 1.38× 1.05× 5.04× 0.53× 0.53× 187.69×
Accruals Ratio -0.08× -0.01× -0.23× -0.06× — 0.15×
SBC % of Revenue 1.00% 0.64% 0.37% 0.46% 0.46% 0.87%
CapEx Coverage 7.39× 7.01× 13.19× -3.22× -3.22× -4.02×
Free Cash Flow Per Share $4.63 $2.86 $3.44 $-1.03 $-1.03 $-2.50

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2024FY 2021
P/E Trailing (Diluted) 14.94× 15.33× 28.85× — — —
P/FCF 12.51× 16.96× 6.21× — — —
FCF Yield 8.00% 5.90% 16.09% — — —
EV / EBITDA 9.38× 9.97× 11.01× — — 37.32×
P/S 1.25× 1.16× 0.61× 0.33× 0.32× 0.85×
P/B 7.23× 9.80× 17.17× 193.49× 187.42× —

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2024FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 1.48B 1.35B 1.13B 800.64M 800.64M 684.00M
Revenues 1.48B 1.35B 1.13B 800.64M 800.64M 684.00M
Cost of Revenue 1.18B 1.09B 993.94M 764.09M 764.09M 611.85M
Gross Profit 303.51M 256.16M 138.85M 36.55M 36.55M 72.14M
Research and Development Expense 15.20M 9.40M 6.60M 6.10M 6.10M 5.20M
Selling, General and Administrative Expense 136.35M 116.83M 87.19M 77.25M 77.25M 65.62M
Operating Income (Loss) 167.17M 139.33M 51.66M -40.70M -40.70M 6.52M
Income Tax Expense (Benefit) 43.93M 33.23M 8.95M -11.45M -11.45M -1.19M
Net Income (Loss) Attributable to Parent 127.72M 105.55M 23.81M -45.76M -45.76M -289.00K
Earnings Per Share, Basic $4.01 $3.27 $0.74 $-1.48 $-1.48 $-0.01
Weighted Average Number of Shares Outstanding, Basic 31.86M 32.27M 32.07M 31.02M 31.02M 27.14M
Earnings Per Share, Diluted $3.88 $3.16 $0.74 $-1.48 $-1.48 $-0.01
Weighted Average Number of Shares Outstanding, Diluted 32.88M 33.35M 32.26M 31.02M 31.02M 27.14M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2024FY 2021
Cash and Cash Equivalents, at Carrying Value 229.31M 127.69M 78.99M 10.48M — 11.71M
Assets, Current 411.63M 323.38M 236.06M 174.48M — 156.07M
Assets 625.25M 524.89M 417.77M 366.13M — 356.02M
Liabilities, Current 236.80M 235.97M 229.62M 164.77M — 124.78M
Long-term Debt, Excluding Current Maturities 85.32M 89.99M 110.54M 130.39M — 149.57M
Stockholders' Equity Attributable to Parent 255.41M 159.56M 40.00M 1.38M — -32.66M
Common Stock, Shares, Outstanding 31.88M 32.27M 32.17M 32.02M — 27.21M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2024FY 2021
Net Cash Provided by (Used in) Operating Activities 176.21M 111.11M 119.93M -24.44M -24.44M -54.24M
Net Cash Provided by (Used in) Investing Activities -23.87M -15.81M -8.52M -6.45M -6.45M -11.31M
Payments for Repurchase of Common Stock 9.89M 1.18M 376.00K 1.71M 1.71M 517.00K
Net Cash Provided by (Used in) Financing Activities -50.72M -46.60M -42.90M 29.66M 29.66M 32.75M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (BLBD CIK 0001589526), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

WINA

WINMARK CORPORATION

ELTX

Elicio Therapeutics, Inc.

NSIT

INSIGHT ENTERPRISES, INC.